A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

A new tally finds that nearly half of the U.S. adult population might be eligible to take semaglutide to battle obesity, ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Results demonstrated the mean total medical costs per patient per year decreased significantly after patients began ...